Kangji Medical Holdings Management
Management criteria checks 4/4
Kangji Medical Holdings' CEO is Ming Zhong, appointed in Aug 2004, has a tenure of 20.42 years. total yearly compensation is CN¥1.23M, comprised of 96.2% salary and 3.8% bonuses, including company stock and options. directly owns 33.79% of the company’s shares, worth HK$2.46B. The average tenure of the management team and the board of directors is 4.4 years and 4.8 years respectively.
Key information
Ming Zhong
Chief executive officer
CN¥1.2m
Total compensation
| CEO salary percentage | 96.2% |
| CEO tenure | 20.4yrs |
| CEO ownership | 33.8% |
| Management average tenure | 4.4yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Are Investors Undervaluing Kangji Medical Holdings Limited (HKG:9997) By 47%?
Nov 22
Investors Could Be Concerned With Kangji Medical Holdings' (HKG:9997) Returns On Capital
Apr 12Kangji Medical Holdings Limited (HKG:9997) Shares Could Be 32% Above Their Intrinsic Value Estimate
Mar 08Kangji Medical Holdings Limited's (HKG:9997) Share Price Not Quite Adding Up
Dec 21Kangji Medical Holdings' (HKG:9997) Returns On Capital Not Reflecting Well On The Business
Oct 23Should You Be Adding Kangji Medical Holdings (HKG:9997) To Your Watchlist Today?
Aug 17A Look At The Intrinsic Value Of Kangji Medical Holdings Limited (HKG:9997)
Jul 28Kangji Medical Holdings (HKG:9997) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Put Kangji Medical Holdings (HKG:9997) On Your Watchlist?
May 01Some Shareholders Feeling Restless Over Kangji Medical Holdings Limited's (HKG:9997) P/E Ratio
Apr 13A Look At The Fair Value Of Kangji Medical Holdings Limited (HKG:9997)
Mar 28Here's Why Kangji Medical Holdings (HKG:9997) Has Caught The Eye Of Investors
Jan 03Are Kangji Medical Holdings Limited (HKG:9997) Investors Paying Above The Intrinsic Value?
Sep 21Kangji Medical Holdings (HKG:9997) Is Reinvesting At Lower Rates Of Return
Jun 12Kangji Medical Holdings' (HKG:9997) Shareholders Will Receive A Bigger Dividend Than Last Year
May 16Kangji Medical Holdings (HKG:9997) Will Pay A Larger Dividend Than Last Year At HK$0.17
May 02Returns On Capital At Kangji Medical Holdings (HKG:9997) Paint A Concerning Picture
Dec 20Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers
Mar 31Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative
Feb 03
Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?
Dec 30An Intrinsic Calculation For Kangji Medical Holdings Limited (HKG:9997) Suggests It's 42% Undervalued
Nov 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥534m |
| Mar 31 2024 | n/a | n/a | CN¥519m |
| Dec 31 2023 | CN¥1m | CN¥1m | CN¥504m |
| Sep 30 2023 | n/a | n/a | CN¥540m |
| Jun 30 2023 | n/a | n/a | CN¥576m |
| Mar 31 2023 | n/a | n/a | CN¥528m |
| Dec 31 2022 | CN¥1m | CN¥1m | CN¥479m |
| Sep 30 2022 | n/a | n/a | CN¥447m |
| Jun 30 2022 | n/a | n/a | CN¥415m |
| Mar 31 2022 | n/a | n/a | CN¥436m |
| Dec 31 2021 | CN¥1m | CN¥990k | CN¥457m |
Compensation vs Market: Ming's total compensation ($USD168.04K) is below average for companies of similar size in the Hong Kong market ($USD463.73K).
Compensation vs Earnings: Ming's compensation has been consistent with company performance over the past year.
CEO
Ming Zhong (48 yo)
20.4yrs
Tenure
CN¥1,232,000
Compensation
Mr. Ming Zhong serves as Executive Director of Kangji Medical Holdings Limited since March 7, 2020 and Chief Executive Officer since August 24, 2004 and is its Executive Chairman since May 2024. He is main...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board & CEO | 20.4yrs | CN¥1.23m | 33.79% HK$ 2.5b | |
| Vice GM & Executive Director | 8.2yrs | CN¥1.03m | 19.15% HK$ 1.4b | |
| Vice GM & Executive Director | 4.8yrs | CN¥1.94m | no data | |
| Chief Financial Officer | 1.3yrs | no data | no data | |
| Head of Domestic Sales & Marketing | 4yrs | no data | no data | |
| Company Secretary | 2.7yrs | no data | no data |
4.4yrs
Average Tenure
45.5yo
Average Age
Experienced Management: 9997's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board & CEO | 4.9yrs | CN¥1.23m | 33.79% HK$ 2.5b | |
| Vice GM & Executive Director | 4.8yrs | CN¥1.03m | 19.15% HK$ 1.4b | |
| Vice GM & Executive Director | 2.8yrs | CN¥1.94m | no data | |
| Independent Non-Executive Director | 4.8yrs | CN¥102.00k | no data | |
| Non-Executive Director | 4.8yrs | no data | no data | |
| Independent Non-Executive Director | 4.8yrs | CN¥102.00k | no data | |
| Independent Non-Executive Director | 4.8yrs | CN¥102.00k | no data |
4.8yrs
Average Tenure
49yo
Average Age
Experienced Board: 9997's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 21:41 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kangji Medical Holdings Limited is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Bo Li | CLSA |
| Chris Pan | Goldman Sachs |